Yet, three are several unsolved questions about the underlying mechanism of CASC11 up-regulation in cancers, possible impact of genetic polymorphisms on its function and activity, the role of epigenetic factors in its regulation and the interactions between CASC11 and other regulatory biomolecules. This evidence concerns the gene CASC11 and cancer.